B-cell Non-hodgkin Lymphoma

• CLINICAL_TRIALS research · 2024-07-11
  Clinical Trial Update: A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

  This clinical trial update describes a study evaluating the efficacy and safety of glofitamab in combination with salvage therapy for relaps…

• CLINICAL_TRIALS research · 2024-05-03
  Clinical Trial Update: Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

  Clinical trial update for allogeneic CARCIK-CD19 in adults and children with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia; Ph…

• CLINICAL_TRIALS research · 2017-04-11
  Clinical Trial Update: Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL) [Phase 2]

  This document describes an ongoing Phase 2 clinical trial evaluating chidamide in combination with the DICE regimen for relapsed or refracto…

• CLINICAL_TRIALS research · 2016-06-09
  Clinical Trial Update: CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies [Phase 1, Phase 2]

  This entry reports a phase 1/2 clinical trial of a CD22-targeted CAR-T therapy for recurrent or refractory B-cell malignancies; the status i…

• CLINICAL_TRIALS research · 2015-08-20
  Clinical Trial Update: Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection [Phase 1]

  A terminated Phase 1 clinical trial evaluated ibrutinib for relapsed or refractory B-cell non-Hodgkin lymphoma in adults with HIV infection.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2015-05-28
  Clinical Trial Update: A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma [Phase 2]

  A Phase 2 pharmacokinetic study comparing SCT400 with rituximab in patients with B-cell non-Hodgkin lymphoma.

• CLINICAL_TRIALS research · 2014-11-06
  Clinical Trial Update: Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes [Phase 1, Phase 2]

  This entry provides an update on a phase 1/2 gene therapy trial using CD19 CAR-T cells to treat relapsed or refractory B-cell non-Hodgkin ly…

• CLINICAL_TRIALS research · 2014-07-24
  Clinical Trial Update: S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

  This clinical trial update reports a completed study examining gene analyses in tissue samples from patients with B-cell non-Hodgkin lymphom…

• CLINICAL_TRIALS research · 2012-08-28
  Clinical Trial Update: Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

  This clinical trial update describes a Phase 1/2 study of a Rituximab, Fludarabine, Cyclophosphamide, and Yttrium-90 ibritumomab tiuxetan re…